TW200514552A - A constituent for preventing of memory lose and dementia - Google Patents

A constituent for preventing of memory lose and dementia

Info

Publication number
TW200514552A
TW200514552A TW092128775A TW92128775A TW200514552A TW 200514552 A TW200514552 A TW 200514552A TW 092128775 A TW092128775 A TW 092128775A TW 92128775 A TW92128775 A TW 92128775A TW 200514552 A TW200514552 A TW 200514552A
Authority
TW
Taiwan
Prior art keywords
dementia
constituent
preventing
memory
lose
Prior art date
Application number
TW092128775A
Other languages
Chinese (zh)
Other versions
TWI259771B (en
Inventor
Ming-Tsun Hsieh
Ming-Jin Lv
Wen-Huang Peng
Wei-Zhe Li
Original Assignee
Ming-Tsun Hsieh
Ming-Jin Lv
Wen-Huang Peng
Wei-Zhe Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ming-Tsun Hsieh, Ming-Jin Lv, Wen-Huang Peng, Wei-Zhe Li filed Critical Ming-Tsun Hsieh
Priority to TW92128775A priority Critical patent/TWI259771B/en
Publication of TW200514552A publication Critical patent/TW200514552A/en
Application granted granted Critical
Publication of TWI259771B publication Critical patent/TWI259771B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention is concerning the use of emodin to promote the memory. In particular, the invention is concerning a kinds of treatments and/ or prevention of memory lose and Dementia. Its major active constituents contain emodin.
TW92128775A 2003-10-16 2003-10-16 A medical composition for treatments and prevention of memory lose TWI259771B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW92128775A TWI259771B (en) 2003-10-16 2003-10-16 A medical composition for treatments and prevention of memory lose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW92128775A TWI259771B (en) 2003-10-16 2003-10-16 A medical composition for treatments and prevention of memory lose

Publications (2)

Publication Number Publication Date
TW200514552A true TW200514552A (en) 2005-05-01
TWI259771B TWI259771B (en) 2006-08-11

Family

ID=37872507

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92128775A TWI259771B (en) 2003-10-16 2003-10-16 A medical composition for treatments and prevention of memory lose

Country Status (1)

Country Link
TW (1) TWI259771B (en)

Also Published As

Publication number Publication date
TWI259771B (en) 2006-08-11

Similar Documents

Publication Publication Date Title
EP1894564A3 (en) Use of an ibat inhibitor for the treatment of prophylaxis of constipation
WO2002089791A3 (en) Acne treatment with lipooxigenase inhibitors
HK1074592A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MY135721A (en) Amidino compounds useful as nitric oxide synthase inhibitors
WO2005115547A3 (en) Myricitrin compounds for sleeping disorders
MXPA05013147A (en) Solid pharmaceutical preparation.
MXPA03008045A (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors.
WO2006016262A8 (en) Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor
IL174536A (en) Combination comprising candesartan and rosuvastatin, pharmaceutical compositions comprising such combination and use of such combination as a medicament for the prevention or treatment of atherosclerosis or cardiovascular events
EP1419785A4 (en) Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
WO2004019868A3 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
WO2003065789A3 (en) N-biphenylmethyl aminocycloalkanecarboxamide derivatives
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
ZA200400313B (en) Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine.
ZA200210316B (en) Composition and its therapeutic use.
MX2007007355A (en) 5-(2,2-dimethyl-cycloprodyl)-3-methyl-pen-2-enenitrile as fragrance and flavour.
EP1541139A4 (en) Drug composition containing nf-kappa b inhibitor
AR043327A1 (en) USE OF QUINURENINE 3- HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES
WO2004083173A3 (en) Ketopiperazine derivatives as bradykinin antagonists
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
TW200514552A (en) A constituent for preventing of memory lose and dementia
CA98129S (en) Storage case